
Stereotaxis Inc (STXS) Stock Forecast & Price Target
Stereotaxis Inc (STXS) Analyst Ratings
Bulls say
Stereotaxis Inc. is projected to experience substantial revenue growth, with forecasts indicating increases of 24% for system sales and 25% for disposables, driven by the adoption of new systems and catheter utilization. In the second quarter of FY26, the company reported a 95% year-over-year increase in revenue, reaching $8.8 million, while recurring revenue rose 35% to $5.8 million, underscoring strong demand for robotic-assisted procedures. Additionally, significant regulatory advancements related to the company's next-generation robotic systems and catheters are expected to enhance revenue streams and operational leverage, further supporting optimistic financial projections for FY26.
Bears say
Stereotaxis Inc. faces a challenging financial outlook due to several key factors affecting its performance. The company reported a net loss of $3.8 million, with ongoing cash runway issues indicating a need for additional financing, which could dilute shareholder value. Furthermore, potential delays in product approvals, supply chain challenges, and competitive pressures from alternative approaches in the market could hinder revenue growth and further complicate efforts to achieve profitability.
This aggregate rating is based on analysts' research of Stereotaxis Inc and is not a guaranteed prediction by Public.com or investment advice.
Stereotaxis Inc (STXS) Analyst Forecast & Price Prediction
Start investing in Stereotaxis Inc (STXS)
Order type
Buy in
Order amount
Est. shares
0 shares